Aiosyn is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide.
We focus on developing, integrating, and certifying AI solutions for clinical diagnostic support for complex diseases such as prostate and breast cancer. We also provide solutions for biotech, pharma and diagnostics companies looking to improve their pathology workflows with AI.
Location: Netherlands, Gelderland, Nijmegen
Member count: 11-50
Total raised: $2.123701M
Founded date: 2021
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.12.2022 | - | $2.123701M | - | vcbay.news... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 23.12.2022 | Healthtech... | Netherlands-based company deve... | - | - | vcbay.news... |
| 22.12.2022 | Dutch-base... | Netherlands-based Aiosyn, a st... | funding N... | Vishal Sin... | siliconcan... |
| 22.12.2022 | Dutch star... | - | - | - | eu-startup... |
| 21.12.2022 | Aiosyn rai... | Pathology is indispensable in ... | - | - | oostnl.com... |
| - | Aiosyn | “Achieve more perspective - Ai... | - | - | fastfounde... |